Att 2_60dFY2020DV

Federal Register / Vol. 88, No. 122 / Tuesday, June 27, 2023 / Notices
speaker may only speak once per
meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
(Authority: 5 U.S.C. 1001 et seq.)
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–13547 Filed 6–26–23; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–1305; Docket No. CDC–2023–
0054]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled ‘‘Chronic Q
fever in the United States: Enhanced
Clinical Surveillance’’. This enhanced
medical surveillance for chronic Q fever
will collect specific clinical data not
otherwise collected during routine
public health surveillance to allow for
better characterization of the clinical
presentation and risk factors of chronic
Q fever in the United States.
DATES: CDC must receive written
comments on or before August 28, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2023–
0054 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.

ddrumheller on DSK120RN23PROD with NOTICES1

SUMMARY:

VerDate Sep<11>2014

18:54 Jun 26, 2023

Jkt 259001

• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 3501–3520),
federal agencies must obtain approval
from the Office of Management and
Budget (OMB) for each collection of
information they conduct or sponsor. In
addition, the PRA also requires federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each new proposed
collection, each proposed extension of
existing collection of information, and
each reinstatement of previously
approved information collection before
submitting the collection to the OMB for
approval. To comply with this
requirement, we are publishing this
notice of a proposed data collection as
described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or

PO 00000

Frm 00044

Fmt 4703

Sfmt 4703

41629

other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Chronic Q fever in the United States:
Enhanced Clinical Surveillance (OMB
Control No. 0920–1305, Exp. 9/30/
2023)—Revision—National Center for
Emerging Zoonotic and Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Q fever is a worldwide zoonosis
caused by Coxiella burnetii with acute
and chronic disease presentations.
Chronic Q fever can manifest months to
years after the primary infection and is
rare, occurring in <5% of persons with
an acute infection. Chronic Q fever can
take on several clinical forms, including
endocarditis, chronic hepatitis, chronic
vascular infections, osteomyelitis, and
osteoarthritis.
In the United States, Q Fever cases are
reported via the National Notifiable
Disease Surveillance System (NNDSS,
OMB Control No. 0920–0728); however,
limited information is collected on the
various clinical manifestations of
chronic Q fever or patients pre-existing
risk factors. Data on outcomes other
than death or hospitalizations are not
collected by the current surveillance.
Because of this lack of data, the true
burden and proportion of cases
exhibiting endocarditis and other forms
of chronic Q fever in the United States
is unknown. We plan to establish an
enhanced medical surveillance for
chronic Q fever by working with
consulting clinicians to gather
additional and more specific clinical
data not otherwise collected during the
course of routine public health
surveillance for chronic Q fever. This
information will allow for better
characterization of the clinical
presentation and risk factors of chronic
Q fever in the United States. The results
will help characterize an underrecognized disease and provide valuable
data to educate physicians on
identifying and diagnosing these cases.
Recently, there has been an increased
volume of clinical consultation requests.
To reflect this, we are proposing an
increase in the number of respondents
to 50 each year. Additionally, the
clinical course for these patients is often
complex, and clinical relapse or
prolonged infection has been reported.
To capture these important clinical
details, we propose increasing the
number of total instruments to two, with
a follow-up survey that will take five
minutes each at six, 12, 18, and 24

E:\FR\FM\27JNN1.SGM

27JNN1

41630

Federal Register / Vol. 88, No. 122 / Tuesday, June 27, 2023 / Notices

months from the date of the initial
consult. CDC requests OMB approval for
an estimated 26 annual burden hours.

There is no cost to respondents other
than their time to participate.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)

Total burden
(in hours)

Form name

Physician .......................

Chronic Q Fever Enhanced Surveillance Report
Form—Initial Consult.
Chronic Q Fever Enhanced Surveillance Report
Form—Follow-Up.

50

1

20/60

17

50

2

5/60

9

..............................................................................

........................

........................

........................

26

Physician .......................
Total ........................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–13573 Filed 6–26–23; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–1175]

Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Environmental
Public Health Tracking Network
(Tracking Network)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on December
20, 2022 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
ddrumheller on DSK120RN23PROD with NOTICES1

Number of
responses per
respondent

Number of
respondents

Type of respondents

(a) Evaluate whether the proposed
collection of information is necessary for the
proper performance of the functions of the
agency, including whether the information
will have practical utility;
(b) Evaluate the accuracy of the agencies
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and assumptions
used;

VerDate Sep<11>2014

18:54 Jun 26, 2023

Jkt 259001

(c) Enhance the quality, utility, and clarity
of the information to be collected;
(d) Minimize the burden of the collection
of information on those who are to respond,
including, through the use of appropriate
automated, electronic, mechanical, or other
technological collection techniques or other
forms of information technology, e.g.,
permitting electronic submission of
responses; and
(e) Assess information collection costs.

To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Environmental Public Health
Tracking Network (Tracking Network)
(OMB Control No. 0920–1175, Exp. 7/
31/2023)—Revision—National Center
for Environmental Health (NCEH),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The CDC is submitting a three-year
Paperwork Reduction Act (PRA)
Revision Information Collection Request
(ICR) for ‘‘Environmental Public Health
Tracking Network (Tracking Network)’’
(OMB Control No. 0920–1175,
Expiration Date 7/31/2023). This ICR is
sponsored by the Environmental Public
Health Tracking Section (Tracking

PO 00000

Frm 00045

Fmt 4703

Sfmt 4703

Section), Division of Environmental
Health Science and Practice (DEHSP),
National Center for Environmental
Health (NCEH) at CDC.
In September 2000, the Pew
Environmental Health Commission
issued a report entitled America’s
Environmental Health Gap: Why the
Country Needs a Nationwide Health
Tracking Network. The Commission
documented a critical gap in
‘‘knowledge that hinders our national
efforts to reduce or eliminate diseases
that might be prevented by better
managing environmental factors’’ due
largely to the fact that existing
environmental health systems were
inadequate and fragmented. They
described a lack of data for the leading
causes of mortality and morbidity, a
lack of data on exposure to hazards, a
lack of environmental data with
applicability to public health, and
barriers to integrating and linking
existing data. To address this critical
gap, the Commission recommended a
‘‘Nationwide Health Tracking Network’’
for disease and exposures. In response
to the report and this critical gap,
Congress appropriated funds in the
fiscal year 2002 budget for the CDC to
establish the National Environmental
Public Health Tracking Program
(Tracking Program) and Network and
has appropriated funds each year
thereafter to continue this effort.
The Tracking Program includes State
and Local Health Departments (SLHD)
which collaborate to: (1) build and
maintain the Tracking Network; (2)
advance the practice and science of
environmental public health tracking;
(3) communicate information to guide
environmental health policies and
actions; (4) enhance tracking workforce
and infrastructure; and (5) foster
collaborations between health and
environmental programs.
In spring of 2022, under Notice of
Funding Opportunity CDC–RFA–EH22–
2202, the CDC’s Tracking Program

E:\FR\FM\27JNN1.SGM

27JNN1